Cardiff Oncology (CRDF) PT Raised to $25 at Maxim Group
Tweet
Share
E-mailGet Alerts CRDF Hot Sheet
Price: $3.99 -4.55%
Rating Summary:
6 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 1
Rating Summary:
6 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 1
Join SI Premium – FREE
Maxim Group analyst Naureen Quibria raised the price target on Cardiff Oncology (NASDAQ: CRDF) to $25.00 (from $20.00) while maintaining a Buy rating.
You May Also Be Interested In
- Cardiff Oncology to Report First Quarter 2024 Results and Provide Business Update
- Canaccord Genuity Downgrades Antofagasta Plc. (ANTO:LN) (ANFGF) to Hold
- Telia Co AB (TELIA:SS) (TLSNF) PT Lowered to SEK29 at Barclays
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
